Companies: 10,795·Total market cap: $144.5T
Generation Bio Co.

Generation Bio Co.

GBIONASDAQHealthcare
$5.34
+$0.00(+0.00%)
Market Cap$35983830
P/E Ratio
52W High$7.516
52W Low$3.004

Generation Bio Co. (GBIO) Revenue

Annual & quarterly revenue history · segment & region breakdown

GBIO · revenue · updated Jun 10, 2026

Core revenue metrics

Generation Bio Co. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.

TTM revenue
$0.00B
4-quarter sum · USD
YoY growth
+0.00%
vs FY
Price / sales
mktCap ÷ TTM rev
Revenue per day
Est. TTM ÷ 365
Revenue / employee
$0K
115 employees
FY
FY
5Y CAGR
Fiscal year end
Dec 31
Currency
USD · GAAP
Filing
10-K / 10-Q
Source: FMP · Generation Bio Co. SEC filings · GAAPUpdated: 2026-06-10

Revenue trend

· Annual
YoY revenue growth %
revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year endRevenueChangeGrowth
GBIO revenue by year · GBIO revenue history · GBIO annual revenue data

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income Generation Bio Co. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

Generation Bio Co. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from Generation Bio Co.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Frequently asked questions

GBIO revenue · 4 questions

GBIO's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.

GBIO revenueGBIO annual revenuewhat is GBIO revenueGBIO TTM revenue

Source: FMP · Generation Bio Co. SEC filings · GAAP · Generation Bio Co. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 10, 2026